In this study, the immunity of umbilical cord blood (UCB) T lymphocytes against allo-antigens was investigated by a standard MLC. No significant difference, between the UCB T cells or peripheral blood (PB) mature T cells, was observed in the primary responses (stimulation index (SI), 51.8 ؎ 14.8 and 46.5 ؎ 15.0, respectively). In contrast, in the secondary response, the SI obtained with the CD4 T cells from UCB decreased dramatically (16.3 ؎ 6.4), while it increased with the CD4 T cells from PB (118.5 ؎ 21.7). UCB (CD4 and CD8) T cells separately showed much higher frequencies of apoptosis after a primary allo-priming, compared with PB CD4 and CD8 T cells (CD4, UCB 30.5% vs PB 0.8%; CD8, UCB 32% vs PB 1.3%). The higher apoptotic level of the UCB CD4 T cells was confirmed by a second, ELISA-based, Tunel assay (OD values, UCB CD4 1.93 ؎ 0.31 vs PB CD4 0.59 0.9; P Ͻ 0.01). Those apoptotic steps were not attributed to the amount of cytokine (IL-2, 4 and IFN-gamma) production, which was found to be similar in both cases. In conclusion, UCB lymphocytes are much more likely to be induced to apoptosis by allo-priming than adult lymphocytes. This supports their possible, successful engraftment across barriers of HLA incompatibility. Keywords: cord blood; MLR; apoptosis Human umbilical cord blood (UCB) is considered to be a good source of stem cells for transplantation, especially in BM insufficiency or malignant hematological disorders such as leukemia. [1] [2] [3] [4] [5] The unique nature of UCB is its immunological immaturity, which should contribute to a low incidence of GVHD in allogeneic stem cell transplantation. 5 Much research has been conducted to clarify the characteristics of UCB lymphocytes. In summary, it has been reported that UCB has fewer CD3-positive T lymphocytes, 6-10 among which the majority express the naive, nonprimed CD45RA marker, and express fewer IL-2 receptor Correspondence: Dr M Hagihara, Department of Hematology and Rheumatology, Tokai University School of Medicine, Bohseidai, Isehara, Kanagawa 259-1193, Japan Received 29 April 1999; accepted 18 July 1999 molecules than adult PBL.
Human umbilical cord blood (UCB) is considered to be a good source of stem cells for transplantation, especially in BM insufficiency or malignant hematological disorders such as leukemia. [1] [2] [3] [4] [5] The unique nature of UCB is its immunological immaturity, which should contribute to a low incidence of GVHD in allogeneic stem cell transplantation. 5 Much research has been conducted to clarify the characteristics of UCB lymphocytes. In summary, it has been reported that UCB has fewer CD3-positive T lymphocytes, [6] [7] [8] [9] [10] among which the majority express the naive, nonprimed CD45RA marker, and express fewer IL-2 receptor Correspondence: Dr M Hagihara, Department of Hematology and Rheumatology, Tokai University School of Medicine, Bohseidai, Isehara, Kanagawa 259-1193, Japan Received 29 April 1999; accepted 18 July 1999 molecules than adult PBL. 8 However, there is controversy about the immunoreactivity of UCB lymphocytes against allo-antigens. [11] [12] [13] [14] [15] [16] While the majority of studies demonstrated that UCB lymphocytes have a lower proliferative potential than BM or PB lymphocytes, [11] [12] [13] others argue against that theory and have reported that UCB T lymphocytes have a potential to proliferate as strongly as PB T lymphocytes. [14] [15] [16] Several recent studies further examined the immunological nature of UCB or neonatal lymphocytes and showed that programmed cell death (apoptosis) is a key phenomenon for immunological tolerance or anergy. [17] [18] [19] Compared with PBL, the UCB cells were resistant to apoptosis upon stimulation with anti-CD3 MoAb. However, when challenged repeatedly, they were triggered to apoptosis. 20 With this background, we conducted a study to observe not only primary, but also secondary allo-response of UCB T cells, together with the process of apoptosis, in order to elucidate the probability of successful engraftment of UCB stem cells, even in HLA mismatched pairs.
Materials and methods

Cells
UCB were harvested using a syringe with an anti-coagulant (10% ACD solution; Terumo Co. Ltd, Tokyo, Japan) from normal deliveries at Tokai University Hospital, and PB cells were obtained from normal healthy volunteers, with an age range between 25 and 40 years old. Informed consent was provided by each subject. UCB and PB mononuclear cells were purified by density gradient centrifugation, using 1.077 g/cm 3 of Ficoll-Conray.
MLC and mitogen (PHA) stimulation
The proliferative capacity was assessed by MLR. For primary MLC, UCB or PB responder whole lymphocytes (6 ϫ 10 4 /100 l), were incubated with HLA-DR nonidentical PB lymphocytes (6 ϫ 10 4 /100 l), which were pre-treated with 15 Gy of gamma-radiation, and cultured for 6 days in 96-well round-bottom plates (Iwakiglass Co. Ltd, Chiba, Japan) at 37°C in 5% CO 2 . The cells were pulsed with 1 Ci/well of Norway). Incorporation of the radioisotope was measured by a liquid scintillation counter (Packard Instruments, Meriden, CT, USA). In all combinations, the responder and stimulator were HLA-DR 1 or 2 antigen mismatched, and CD4 T lymphocytes were the main responders in the primary culture.
For secondary MLC, responders were collected from wells of primary MLC, then incubated with anti-CD4 mAbconjugated immunobeads (Dynabeads M-280, sheep antimouse lgG; Dynal, Oslo, Norway). Positively selected CD4-positive T lymphocytes were detached from beads using DETACHaBEADs (Dynal), and after washing and readjustment (3 ϫ 10 4 /well), were restimulated with the same number of stimulators for an additional 4 days under the same conditions as in the primary MLC. Then, radioisotope activity was counted in the same way. Stimulation index (SI) was calculated by dividing each c.p.m. value by control c.p.m. (= responders alone). UCB or PB cells were also stimulated with 0.1% PHA (GIBCO BRL, Life Technologies, Rockville, MD, USA) for 3 days, then those cells at the end of culture were also checked for the level of apoptosis.
Detection of apoptosis
The CD4 or CD8 T cells, which were similarly separated with anti-CD8 conjugated immunobeads, just after primary MLC or PHA stimulation was assessed for the level of apoptosis using the In Situ Cell Death Detection Kit, Fluorescein (Boehringer Mannheim, Mannheim, Germany), and CD4 T cells were further examined by Cell Death Detection ELISA-plus kit (Boehringer Mannheim). Both methods, which are known as Tunel assays, detect DNA fragments enriched in the cytoplasm of dying cells using anti-histone and anti-DNA antibodies. The OD of the reaction was counted by Thermomax microplate reader (Molecular Devices, Menlo Park, CA, USA). In another set, CD4 or CD8 T cells from UCB or PB were purified from the beginning of the culture, and were then allo-primed similarly and examined for apoptosis by the former assay.
Cytokine production
Supernatants from the primary MLC were harvested sequentially (at 1, 3, 5 days after the start of the culture), and were stored at Ϫ20°C. The different concentrations of the IL-2, IL-4 and IFN-gamma were measured by ELISA kits following the instruction of the manufacture (Iwakiglass).
Statistical analysis
The difference in mean values among groups was calculated by the Mann-Whitney U test.
Results
Primary and secondary MLC
The results of six separate experiments using 13 different UCB and 10 PB samples, comparing the proliferative response in primary and secondary MLC by the incorporation of the 3 H-thymidine, showed that, in the primary MLC, UCB lymphocytes responded to allo-antigens as strongly as PBL (SI, 51.8 Ϯ 14.5 vs 46.5 Ϯ 15.0). In contrast, in the secondary MLC, the response of PB-CD4 T cells, separated from the primary MLC as described in Materials and methods, to the same allo-stimulators was increased (SI, 118.5 Ϯ 21.7), while that of UCB-CD4 T cells was dramatically decreased (SI, 16.3 Ϯ 6.4). A statistically significant difference (P Ͻ 0.01) was shown for secondary responses between the two groups ( Figure 1) .
Apoptosis
Apoptosis was checked in CD4 or CD8 T cells from UCB and PB after a primary MLC or a PHA stimulation. After those two different stimulations, no difference in the cell viability was found after by the blue trypan exclusion. However, using the FACS-based Tunel assay for the detection of apoptosis, the viable UCB-CD4 or CD8 T cells had a high apoptotic level after the primary MLC compared with the CD4 or CD8 T cells from the PB (CD4 cells, UCB 30.5% vs PB 0.8%; CD8 cells, UCB 32% vs PB 1.3%, Figure 2a ). On the other hand, apoptosis was not induced in the CD4 or CD8 cells from the UCB or PB cells after PHA stimulation (Figure 2b) . When CD4 or CD8 T cells were purified from the beginning of the culture and alloprimed, they did not show a significant level of apoptosis (Figure 2c ). Positive (black histogram) or negative (white Figure 2 The level of apoptosis after MLR (a) or PHA stimulation (b) by FACS-based Tunel assay. CD4 and CD8 T cells were separated by immunobeads, at 6 (for MLR) or 3 days (for PHA) after the beginning of culture, and then examined for apoptosis. The experiments were repeated using three different paired samples, and the representative data are shown here. Cells from UCB only after primary MLC exhibited higher levels (%) of apoptotic change (a (1) UCB-CD4, 30.5%; (2) UCB-CD8, 32%; (3) PB-CD4, 0.8%; (4) PB-CD8, 1.3%; b (1-4) UCB-CD4, CD8, PB-CD4, CD8, respectively: 0%). In another set of experiments, CD4 or CD8 T cells were separated at day 0, and then examined for apoptosis after primary MLC (c (1-4) UCB-CD4, CD8, PB-CD4, CD8, respectively: 0%). Positive (black histogram) or negative (white histogram) control cells included in an assay kit were similarly analyzed, and the region with the intensity over 10 2 was judged as positive (shown in d).
histogram) control cells included in an assay kit were similarly analyzed, and the region with the intensity greater than 10 2 was judged as positive (shown in Figure 2d ). To confirm induction of apoptosis after the primary MLC only in the UCB and not in the PB, we used a second ELISA-based Tunel assay. The CD4 T cells from the UCB were highly apoptotic, and the difference between the UCB and PB was statistically significant (Figure 3 , UCB 1.93 Ϯ 0.31 vs PB 0.59 Ϯ 0.9; P Ͻ 0.01).
Cytokines
The levels of IL-2, IL-4, and IFN-gamma production at each time point (days 1, 3, 5) of the primary MLC were compared and no significant difference was found (Figure 4) .
Discussion
In the present study, we showed that T lymphocytes from UCB are able to respond to allo-antigens similarly to PB T lymphocytes in a primary allo-MLC. However, those T lymphocytes were induced to a state of hyporesponsiveness or unresponsiveness under the secondary challenge with the same allo-stimulators. Risdon et al 16 reported that alloprimed UCB-CD4 T cells were able to respond to secondary allo-antigens, but when combined with UCB-CD8 T cells, the response was reduced. They attributed these findings to a possible anergy induced by the suppressor CD8 T lymphocytes. In our studies, in primary MLC between HLA-DR mismatched pairs, CD4 T cells both from UCB and PB preferentially proliferated equally, and only the UCB or neonatal T cells were found to develop an intrinsic cellular immune tolerance even after in vitro restimulation with superantigen, TSST-1. 17 However, Ridge et al 19 have shown that murine neonatal T cells can be activated by professional APCs or tolerized when costimulated with non-professional APCs. As reported by Steptoe and Thomson, 21 dendritic cells (DC) have tolerogeneic properties. 22 The DC 'tolerogeneic' role could be a major reason in human UCB cell-immune tolerance. Indeed, Hunt et al 23 showed that UCB T cells exhibited as much alloresponding activity as PB T cells, while UCB DC have a lower APC function than those from the PB. Several cytokines, which are produced by T cells or other lineage cells such as monocytes or dendritic cells, are closely involved in the induction of apoptosis and their deprivation can induce apoptosis. 24 In our studies, three representative cytokines (IL-2, 4 and IFN-gamma) were measured at different times during the primary MLC in this study. As no difference on the levels of cytokines between the UCB and the PB was shown, the apoptotic evolution of UCB T cells after the in vitro allo-stimulation was not attributed to the lack or the failure of cytokine production.
Umbilical cord blood is considered as a good, alternative source of hematopoietic stem cell transplantation both in HLA matched and mismatched pairs. 4 Our present data show that UCB T lymphocytes have an intrinsic mechanism to terminate excessive immune activation through the mechanism of apoptosis and support the probability of successful UCB transplantation in histo-incompatible cases.
